Obstetrics & Gynecology Doctors in Worthington, OH Accepting Medicare

7 Obstetrics & Gynecology doctors found. Showing 1 - 7

Deborah A Bartholomew, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 160 W Wilson Bridge Rd Ste 2101, Worthington, OH 43085 Phone: 614-293-3069    Fax: 614-685-0256

Wayne C Trout, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 160 W Wilson Bridge Rd Ste 2101, Worthington, OH 43085 Phone: 614-293-3069    Fax: 614-685-0256

Geri Dawn Hewitt, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 160 W Wilson Bridge Rd Ste 2101, Worthington, OH 43085 Phone: 614-293-3069    Fax: 614-685-0256

Lisa M Keder, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 160 W Wilson Bridge Rd Ste 2101, Worthington, OH 43085 Phone: 614-293-3069    Fax: 614-685-0256

Dr. Katherine E Strafford, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 160 W Wilson Bridge Rd Ste 2101, Worthington, OH 43085 Phone: 614-293-3069    Fax: 614-685-0256

Cynthia B Evans, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 160 W Wilson Bridge Rd Ste 2101, Worthington, OH 43085 Phone: 614-293-3069    Fax: 614-685-0256

Emily Ann Cassell, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 160 W Wilson Bridge Rd Ste 2101, Worthington, OH 43085 Phone: 614-293-3069    Fax: 614-685-0256

News Archive

Less nutritious diet mainly contributes to Type 2 diabetes among U.S.-based South Asians

Less nutritious dietary choices made by South Asians living in developed countries like the U.S. are a key contributor to the group's rising rate of Type 2 diabetes, UT Southwestern researchers report.

Risk Analysis publishes special issue focused on global measles and rubella eradication

Despite goals in every World Health Organization region to eliminate measles by 2020, measles and rubella continue to cause relatively high levels of morbidity and mortality.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Obesity in elderly creating a ticking time bomb for health services in developed countries

Research carried out at the Peninsula Medical School in the South West of England has discovered that obesity in later life does not make a substantial difference to risks of death among older people but that it is a major contributor to increased disability in later life - creating a ticking time bomb for health services in developed countries.

Read more Medical News

› Verified 9 days ago